Literature DB >> 11563784

Efficacy of various laser wavelengths in the treatment of clinically significant macular edema in diabetics.

V Gupta1, A Gupta, R Kaur, S Narang, M R Dogra.   

Abstract

BACKGROUND AND
OBJECTIVE: To compare various laser wavelengths: argon green (514 nm), vs krypton red (647 nm), vs frequency doubled Nd:YAG (532 nm), and vs diode (810 nm), for laser photocoagulation treatment in clinically significant macular edema (CSME) in diabetics. PATIENTS AND METHODS: Four different wavelengths were used to sequentially treat 271 eyes of 164 diabetic patients with CSME. Follow up was conducted for a minimum of 6 months (9.8 +/- 1.3 months). Retreatment was performed if residual edema involving the foveal avascular zone persisted at 3 months.
RESULTS: Reduction/elimination of CSME was observed in 93.3% of argon-treated eyes, 88.5% in krypton red group, 92.9% with frequency doubled Nd:YAG, and 84.8% with diode laser with no statistically significant difference between the groups (P > 0.05 for all groups). The number of eyes requiring retreatment was highest with the diode laser having 44.3% of eyes requiring retreatment and least with frequency doubled Nd:YAG having only 15.5% of eyes requiring retreatment (P = 0.0002).
CONCLUSIONS: All lasers are equally effective in reducing/eliminating CSME. However, Nd:YAG may have an advantage because of requiring fewer retreatments.

Entities:  

Mesh:

Year:  2001        PMID: 11563784

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  2 in total

1.  Subthreshold micropulse diode laser treatment in diabetic macular oedema.

Authors:  M L Laursen; F Moeller; B Sander; A K Sjoelie
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

2.  Effects of subthreshold diode micropulse laser photocoagulation on treating patients with refractory diabetic macular edema.

Authors:  Mohammadreza Akhlaghi; Alireza Dehghani; Reza Pourmohammadi; Leila Asadpour; Mohsen Pourazizi
Journal:  J Curr Ophthalmol       Date:  2018-12-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.